• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nanoparticles permeate lungs to deliver pulmonary drugs

April 11, 2017 By Sarah Faulkner

Nanoparticles permeate lungs to deliver pulmonary drugsResearchers from Johns Hopkins University have developed nanoparticles that can shuttle chemicals through the thick mucus membranes of pulmonary airways to deliver drugs. The team’s work was published in the journal Science Advances. 

Traditional therapies for cystic fibrosis, COPD and asthma include inhaled corticosteroids that adhere to the walls of air passages. Thick mucus tends to build up inside such passageways, creating a challenge for any delivery system.

Instead of trying to make the therapeutics more effective, the team engineered nanoparticles that were small enough to fit through the mucus membranes and get directly to the lining of the lungs. The researchers crafted what they referred to as “mucus-penetrating particles” – nanoparticles that penetrate the mucus membrane, remain in the lungs and release medication for an extended length of time.

The nanoparticles were composed of biodegradable materials that previous work has shown are safe for internal use. The researchers tested their particles in mice and reported that the carriers stayed in the lungs for several hours and were more effective than traditional treatments at reducing asthma symptoms, such as irritation.

The team suggested that their mucus-penetrating particles could offer a more effective treatment plan for patients suffering from lung conditions by providing a treatment that maintains therapeutic drug concentrations and reduces the need for repeat dosing.

Filed Under: Featured, Nanoparticles, Preclinical Trials, Research & Development, Respiratory Tagged With: Johns Hopkins

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS